Parkworth Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Parkworth Wealth Management's AMGN Position: Q2 2025 in Review
Parkworth Wealth Management increased its Amgen (AMGN) stake by 88% in Q2 2025, buying an estimated $1.98K and bringing the position to 15 shares worth $4.19K. The position accounts for ﹤0.01% of the portfolio, ranked #185.
Parkworth Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $5.56K in Q4 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Parkworth Wealth Management held 15 shares of Amgen worth $4.19K as of Q2 2025.
- Parkworth Wealth Management bought 7 Amgen shares in Q2 2025, an estimated $1.98K.
- Amgen made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #185 holding.
- Parkworth Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 3 quarters since.
- Parkworth Wealth Management's Amgen position peaked at $5.56K in Q4 2024.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.